Companies: 10,795·Total market cap: $144.5T
Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDPNASDAQHealthcare● Active
$454.25
$-4.44(-0.97%)
Market Cap$13.0B
P/E Ratio
52W High$628.916
52W Low$293.2
Overview

Medpace Holdings, Inc. (MEDP) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MEDP · as of Jun 8, 2026

Key Statistics

EPS (TTM)$16.24medp eps ttm · medp earnings per shareEarnings history
PE Ratio (TTM)28.0×medp pe ratio ttm · medp price to earningsPE Ratio deep dive
Revenue (TTM)$2.7Bmedp revenue ttm · medp annual revenueFull revenue history
Dividend YieldNo Dividenddoes medp pay dividends · medp dividend yieldDividend history
Shares Outstanding28.8Mmedp shares outstanding · medp floatShares outstanding history
Next EarningsJul 20, 2026Est.medp earnings date · medp next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$2.53B▲ +19.97% YoY
202320242025
medpace holdings, inc. revenue · medp revenue 2025
FY 2025Net Income$451.1M▲ +11.56% YoY
202320242025
medpace holdings, inc. net income · medp profit 2025
FY 2025EPS$15.64▲ +19.75% YoY
202320242025
medp eps · medpace holdings, inc. earnings per share 2025
TTM:Revenue: $2.68BNet Income: $460.4MEPS: $16.24View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold19 analystsis medp a buy · medp analyst rating
Strong Buy
0
Buy
6
Hold
12
Sell
1
Strong Sell
0
12-Month Price Target
$400.00Low
$454.25Current
$498.86Avg Target9.82% upside
$582.00High
medp price target · medp 12 month forecast

Total: 19 · Buy rate: 31.6%

The MEDP analyst consensus is Hold, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $498.86, representing +9.82% upside from the current price of $454.25.

Stock Performance

Full History
1D-0.97%
1W+1.99%
1M+7.13%
3M-3.47%
YTD-19.12%
1Y+52.27%
5Y+164.90%

About Medpace Holdings, Inc.

CEOAugust James Troendle
IPO DateAug 11, 2016
Employees5,900
CountryUS

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical developme…

what is medpace holdings, inc. · medp stock overview · medpace holdings, inc. company profile · who is medpace holdings, inc. ceo · medp NASDAQ · medpace holdings, inc. headquarters · medpace holdings, inc. business segments

About Stock Overview & Key Data

Medpace Holdings, Inc. (MEDP) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Aug 11, 2016. As of the latest trading session, MEDP stock price is $454.25, with a market capitalization of $13.0B. The stock has returned +52.27% over the past 12 months and -19.12% year-to-date.

According to 19 Wall Street analysts, the consensus rating for Medpace Holdings, Inc. stock is Hold, with an average 12-month price target of $498.86. In fiscal year 2025, Medpace Holdings, Inc. reported revenue of $2.5B and net income of $451.1M. For detailed data — including Medpace Holdings, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Medpace Holdings, Inc. (MEDP) stock price is $454.25. The stock is traded on NASDAQ under the ticker symbol MEDP. The 52-week range is $293.20 – $628.92.

MEDP stock priceMEDP quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice